Cours Parnell Pharmaceuticals Holdings Ltd Nasdaq
Actions
AU0000XINEU9
Produits pharmaceutiques
CA 2020 | 30 M 19,86 M 17,9 M | CA 2021 | 34,17 M 22,62 M 20,39 M | Capitalisation | 4,08 k 2,7 k 2,44 k |
---|---|---|---|---|---|
Résultat net 2020 | -15 M -9,93 M -8,95 M | Résultat net 2021 | -1 M -662 k -597 k | VE / CA 2020 | 2,18 x |
Dette nette 2020 | 56,16 M 37,19 M 33,51 M | Dette nette 2021 | 58,89 M 38,99 M 35,14 M | VE / CA 2021 | 1,72 x |
PER 2020 |
-0,56
x | PER 2021 |
-
| Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01/02/10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jay B. Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21/12/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
-15,35% | 76,23 Md | |
-9,19% | 6,67 Md | |
-1,11% | 3,21 Md | |
+6,08% | 1,52 Md | |
-15,13% | 1,37 Md | |
-25,63% | 1,24 Md | |
-7,62% | 1,21 Md | |
-10,84% | 1,17 Md | |
-.--% | 1,05 Md |